A 52-year-old man undergoing interscalene brachial plexus block for rotator cuff repair receives 20 mL of 0.5% bupivacaine. Within 2 minutes of injection, he develops circumoral numbness, tinnitus, and mild restlessness. The anesthesiologist immediately stops the injection and initiates management. Which of the following interventions is NOT indicated in the acute management of this patient's local anesthetic systemic toxicity?

Explanation

## Clinical Scenario: Early-Stage Local Anesthetic Systemic Toxicity **Key Point:** This patient is in the **excitatory phase** of LAST (circumoral numbness, tinnitus, restlessness) — early neurological toxicity that requires immediate intervention to prevent progression to seizures and cardiovascular collapse. ### Recognition of LAST Phases | Phase | CNS Signs | Cardiovascular Signs | Timeline | |-------|-----------|----------------------|-----------| | **Excitatory (early)** | Circumoral numbness, tinnitus, visual disturbances, tremors, restlessness, anxiety | Hypertension, tachycardia | Seconds to minutes | | **Depressant (late)** | Loss of consciousness, apnea | Hypotension, bradycardia, arrhythmias, cardiac arrest | Minutes | This patient is at **high risk of progression** to seizures and cardiovascular collapse if not treated immediately. ### Correct Management Priorities 1. **Stop the injection** ✓ (already done) 2. **Call for help and lipid emulsion** ✓ 3. **Administer 20% lipid emulsion 1.5 mL/kg IV bolus** ✓ - Sequesters bupivacaine away from CNS and cardiac tissue - Repeat bolus every 3–5 minutes if symptoms persist (max 10–12 mL/kg in first hour) - Followed by infusion at 0.25 mL/kg/min 4. **Supplemental oxygen and airway preparation** ✓ - Prevent hypoxemia and hypercarbia (both worsen LAST) - Prepare for intubation if seizures or apnea develop 5. **Seizure control with benzodiazepines or propofol** ✓ - Midazolam or lorazepam for acute seizures - Propofol for seizure prophylaxis (avoid high-dose opioids) 6. **Avoid high-dose vasopressors** ✗ ### Why High-Dose Epinephrine Is Contraindicated **Warning:** High-dose epinephrine (0.1–0.2 mg IV bolus) is **NOT indicated** in LAST because: 1. **Catecholamines worsen arrhythmias** in the presence of high local anesthetic levels - Bupivacaine blocks cardiac sodium channels → increased automaticity and re-entry - Epinephrine increases sympathetic tone → **refractory ventricular fibrillation** 2. **Lipid emulsion is the primary treatment**, not vasopressors 3. **If vasopressors are absolutely necessary** (refractory hypotension despite lipid), use **reduced doses**: - Epinephrine: ≤1 mcg/kg IV bolus (not 0.1–0.2 mg) - Avoid bolus dosing; prefer infusion 4. **Standard ACLS epinephrine dosing is contraindicated** **Clinical Pearl:** The **lipid emulsion acts as a resuscitative agent itself** — by removing local anesthetic from the myocardium, it restores normal cardiac electrophysiology and perfusion. This is why lipid is prioritized over vasopressors in LAST cardiac arrest. ### Management Algorithm for This Patient ```mermaid flowchart TD A["LAST suspected: circumoral numbness, tinnitus, restlessness"]:::outcome A --> B["Stop injection immediately"]:::action B --> C["Call for help + lipid emulsion"]:::action C --> D["Administer 20% lipid 1.5 mL/kg IV bolus over 1 min"]:::action D --> E["Supplemental O₂, prepare airway"]:::action E --> F{"Seizure activity?"}:::decision F -->|Yes| G["Benzodiazepine or propofol"]:::action F -->|No| H["Observe closely, repeat lipid if needed"]:::action G --> I{"Cardiac arrest?"}:::decision I -->|Yes| J["Lipid infusion 0.25 mL/kg/min"]:::action I -->|No| K["Continue monitoring"]:::action J --> L["Reduced-dose vasopressors ONLY if refractory hypotension"]:::action L --> M["Avoid standard ACLS epinephrine doses"]:::urgent ``` **High-Yield:** Remember the **LAST resuscitation mantra**: **Lipid first, vasopressors last — and only at reduced doses.** [cite:Barash Clinical Anesthesia 8e Ch 13; Miller's Anesthesia 8e Ch 16]